|
HS Code |
482118 |
| Iupac Name | Ethyl 1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboxylate |
| Molecular Formula | C17H14FN3O2 |
| Molecular Weight | 311.31 g/mol |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO, DMF; slightly soluble in water |
| Smiles | CCOC(=O)c1cnn2c(c1)ccnc2CC3=CC=CC=C3F |
| Inchi | InChI=1S/C17H14FN3O2/c1-2-23-17(22)12-10-16-15(8-14(12)20-21-16)9-11-6-4-3-5-13(11)18/h3-6,8,10H,2,7,9H2,1H3,(H,20,21) |
| Storage Conditions | Store at -20°C in a dry, dark place |
| Purity | Typically ≥98% (HPLC) |
| Synonyms | No common synonyms |
As an accredited 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams, labeled with chemical name, CAS number, hazard warnings, batch number, and supplier information. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester ensures secure, bulk chemical transport. |
| Shipping | This chemical, **1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester**, is shipped in sealed, chemically resistant containers. It is packaged according to hazardous material regulations, protected from moisture, heat, and light, with proper labeling and documentation to ensure safe transport and compliance with international shipping standards. |
| Storage | Store **1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester** in a tightly sealed container, in a cool, dry, and well-ventilated area, away from incompatible substances such as strong acids or bases. Protect from light and moisture. Ensure that storage is compliant with local regulations and use appropriate labeling. Keep the material away from heat and sources of ignition. |
| Shelf Life | Shelf life of 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester is typically **2–3 years** when stored properly. |
|
Purity 98%: 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester with 98% purity is used in drug discovery research, where high chemical purity ensures reproducible bioassay results. Melting Point 168–172°C: 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester with a melting point of 168–172°C is used in high-throughput compound screening, where thermal stability allows for reliable storage and handling. Molecular Weight 341.34 g/mol: 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester at a molecular weight of 341.34 g/mol is used in pharmacokinetic modeling studies, where precise molecular mass facilitates accurate ADME predictions. Particle Size <10 µm: 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester with particle size below 10 µm is used in solid formulation development, where fine granularity enhances homogeneity and dissolution rates. Stability Temperature up to 60°C: 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester stable up to 60°C is used in chemical process optimization, where elevated temperature stability maintains compound integrity during synthesis. |
Competitive 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In our production facility, every step involved in synthesizing specialty building blocks demands stringent process control. We've learned through decades of chemical manufacturing that there's a world of difference between producing a compound based on a generic synthesis and designing a process that meets the real demands of research chemists. The molecule known as 1H-Pyrazolo[3,4-b]pyridine-3-carboxylic acid,1-[(2-fluorophenyl)methyl]-, ethyl ester delivers that sort of targeted value, bridging rigid structural complexity with a flexible reactivity profile.
On the shop floor, our technicians begin with high-purity starting materials, aiming at crisp, clean transformation routes. Tight temperature control, selective protection steps, and efficient purification make or break the lot’s viability. In our experience, small departures from protocol—be it an off-spec solvent quality or unexpected intermediate shade—invite far-reaching consequences. This product’s importance in heterocycle library construction means every run draws the best of our team’s skill, guided by method validation and inspection that lets us ship consistent lots batch after batch.
Research chemists in pharma and agrochemical labs approach us because their next-generation compounds rest on the stability and functionality of advanced intermediates. The core scaffold of 1H-pyrazolopyridine structures supports investigations into kinase inhibitor pipelines or diversified screening pools. Hard-won experience tells us that substitutions, especially with electron-withdrawing groups like fluoro, tune both solubility and selectivity properties further. Attaching an ethyl ester unit provides a ready hook for subsequent transformations—hydrolysis, amidation, or reductive processing. Chemists don’t always know where a series will lead, but they ask for intermediates that don’t halt progress with unpredictable side reactions. Our close attention to product cleanliness is a direct response to seeing what a single embedded impurity can do in downstream coupling steps.
This product’s synthetic advantage ties back to its fine balance—enough complexity to present as a versatile intermediate, but not so much that it introduces dead-end byproducts or complicates analytical methods. Working at scale has shown that keeping byproduct levels low pays off later, especially as solvent residues and minor isomeric impurities can drag on purification at later stages. Over years of feedback, we have moved away from older, less selective catalysts and found that using safer, more robust reagents brings consistency that research labs value when trying to take a project from a few milligrams to hundreds of grams.
Through direct dialogue with process development groups, we hear again and again that upstream reliability saves time. The lessons we’ve taken to heart from hundreds of successive lots: keep water content tightly monitored, reduce trace organic carryover, and track batch color and melting point from synthesis to shipping. Customers don’t want post-synthesis troubleshooting. Clean product in makes for faster, less wasteful final synthesis, so our focus never wavers from keeping each production run well documented and every warehouse vial source-verified. Each step removes an unknown from a fellow chemist’s bench. When a research team invests months into synthetic sequence buildup, a poorly characterized intermediate can create uncertainty they can’t risk.
Collaborating closely with development teams working on kinase targets or proprietary heterocycles, we’ve seen the need for fast analytical turnaround. Each lot receives full NMR, HPLC, and mass spec confirmation, not just as a box-ticking exercise but as insurance for our customer’s project timelines. No compound moves to shipping unless the results stand up under external scrutiny. That culture of transparency isn’t about regulatory pressure—it reflects real needs from researchers who bet on vendor reliability at every milestone.
Unlike bulk commodity chemicals, this product embodies a deeper partnership between manufacturer and end researcher. Vendors who buy and resell intermediates rarely invest in method optimization, and they seldom feed back details that might refine future synthesis. Over the years, we’ve picked up small improvements from every customer discussion—shifts in reaction pH, tweaks in purification, or alternate solvent choices—that translate to tangible benefit the next time we repeat a batch. Technical support doesn’t end at a warehouse door, because many customers lean on our in-house analytical experience. Each lot ships with not just a batch certificate, but with access to preparative input if a user encounters an unexpected result in their own lab.
We’ve faced direct comparisons with product from trading houses, where inconsistent crystallinity or unusual UV/Vis patterns have complicated downstream chemistry. In retrospect, most stemmed from lack of process oversight before bottling. We train our team to recognize the visual, olfactory, and spectral “fingerprints” that mark out a sound product lot, narrowing the spread batch-to-batch. Our synthesis team and laboratory cross-check every intermediate and final product against an internal reference, cutting down on batch surprises. Institutional memory and shared lessons learned matter more than isolated certificate digits.
On the shop floor and in the warehouse, storage controls reflect on actual batch longevity. Laboratories investing in this chemical don’t want to crack a bottle only to discover clumped product or unexpected solvent odor. Each drum or vial is filled under dry, inert conditions and sealed immediately. Our team reviews shelf stability data based on real observed timelines, not projections or industry averages. Every storage recommendation stems from the collective experience handling outgoing and retained samples—not just theoretical risk calculations.
We supply sterility and stability metrics specific to the compound lot, informed by practical stress testing. Whether it’s the resistance of the ester group to ambient humidity, or the safeguarding of the fluoro-substituted core against slow decomposition, these real-world data reassure R&D groups relying on our transit and storage chain. Teams in both chemistry and logistics understand why a late shipment or a temperature deviation triggers extra spot checks and new sample pulls. Everything revolves around the principle that test tubes in customer labs should open to a product that matches the certificate, visually and analytically. Teams at both ends then move forward, not back.
Producing this derivative at larger than research scales brings specific challenges we’ve navigated repeatedly. Coping with heat management and mixing uniformity in scale-up runs becomes an exercise in adaptation, not copying bench methods. Team members revisit solvent swaps, agitation speeds, even the thickness of filtration media, based on run-to-run feedback. Our plant operators log small shifts in reaction rate, track yield drops, and tie these to variables such as glassware geometry or raw material batch source.
Continuous improvement draws on failure as well as success. We’ve learned that scaling up a reaction sometimes brings contaminants or off-target side reactions that never showed up in gram-scale trials. In response, we revisit process safety windows, retool reaction workups, or build-in extra in-process checks. Scaling up isn't about brute force. Each kill point and quench parameter reflects a tradeoff, managed with careful monitoring and a willingness to scrap questionable partial batches. We track each unexpected variable, creating a feedback loop that refines our methods and reduces risk the next time a similar molecule appears on our production list.
Raw material supply reliability underpins the kind of stability end customers expect. Our sourcing team chooses vendors who provide transparency into their own operations, passing on every certificate tied to base inputs. Over the years, supplier audits and direct site visits have taught us which relationships withstand market volatility. When a key precursor swings in global availability, there’s no substitute for direct dialogue with our input partners. Having seen what can disrupt timelines—a port delay, a purity drop, a missed dry-down—our procurement team tracks each lot number back to origin. This vigilance pays off not just in uptime, but in faster issue tracing if a downstream problem comes up.
Colleagues in research chemistry have voiced stronger sustainability demands, so we integrate greener solvents and recycling options where they work without sacrificing purity. Several developmental projects introduced biobased reagents or improved workup methods, cutting down on energy bills and solvent emissions. These adaptations come from close consultation with regulatory shifts and customer priorities. As regulators increase scrutiny on hazardous waste and solvent use, manufacturers who anticipate and adapt will hold the strategic advantage. We treat each process transition as a live case study, logging what succeeds and what stumbles, for an honest, evolving improvement plan.
One of the more underestimated aspects of our role as a manufacturer involves understanding field-specific troubleshooting. In-house bench chemists openly communicate with their counterparts at customer research labs, often sharing chromatograms, spectral overlays, and routes to identify subtle issues. Insights gained transfer to new batches and even stimulate improvements in analytical method development. Standing relationships with beta-testers help us learn which forms of the molecule (solid, solution, stabilized forms) best support high-throughput screening or flow chemistry workup.
Over time, this feedback culture has led us to offer matched support: if a customer uncovers a tricky side reaction or impurity not previously seen, our product and process team reruns analytical screens or troubleshoots alternate synthesis paths. Instead of offering only a static specification sheet, we view the molecule’s journey through both lens—the producer managing complexity and the innovator seeking an edge. This two-way engagement builds confidence, speeds iteration cycles, and limits costly project delays. Actual technical challenges—whether in solubility tuning, solid-state manipulation, or functional group compatibility—become collaborative projects, not isolated handoffs.
The rise in kinase inhibitor programs, improved crop protection molecules, and next-generation material research all demand a steady supply of thoughtfully synthesized heterocyclic intermediates. Our direct manufacturing experience brings us a vantage to witness how new applications move from concept to reality. Chemists wrestling with lead optimization or exploring new SAR (structure-activity relationship) landscapes seek unique substituents like the fluorophenyl moiety present in this molecule. Each batch placed in researchers' hands supports those trial-and-error sequences that prompt breakthrough innovations.
By tracking literature, consulting with project leaders, and reviewing application notes, we identify which features of the product matter most across diverse projects. For some, handleability in automation platforms becomes paramount. For others, the cleanness of the ester moiety ensures downstream coupling proceeds smoothly. This ongoing dialogue keeps our manufacturing team not just current but predictive—ready to tweak synthetic procedures or tailor lot sizes as the state of the art moves forward.
Veterans on our production floor trade granular lessons: the effect of different stirrer profiles, the quirks of scale-specific heat transfer, or the impact of drying time on crystallization. Our training crosses roles, with analytical chemists mentoring production leads and vice versa. New hires shadow runs, absorbing the tacit knowledge built up over years—identifying a “good” reaction smell, the visual cues of a clean layer break, the right feel of a filtered cake. This culture of experience transfer keeps product quality predictable in an environment where talent turns over and every batch writes a new story.
Even with automation advances, manual intervention plays a central role. Operators log deviations, alert quality teams to off-spec observations, and maintain sightlines to each batch's lifecycle. Each operator plays a part in upholding standards that can’t be captured by digital systems alone. By fostering an environment of responsibility and shared purpose, our team earns the trust essential for long-term partnerships with end users in fast-evolving research sectors.
We believe that responsibility for a chemical intermediate doesn't end at the warehouse door. The relationship between a manufacturer and customer extends through every step—sourcing, synthesis, verification, delivery, and follow-up. Our continued commitment to clean, reliable production is driven by the understanding that even minor oversights can ripple outward, stalling an entire research project or, worse, undermining promising innovation. Real accountability means maintaining open lines for feedback, invitations to visit our facility, and quick adjustments in response to unanticipated needs.
The market for sophisticated heterocycles is expanding, but reliability becomes more crucial as possibilities grow. The value we bring stems not from commodity pricing or generic availability but from a manufacturing process rooted in shared goals, technical rigor, and a relentless pursuit of improvement. Each new inquiry and each shipped batch reaffirms the unique link between the synthetic producer and the research chemist. Together, we navigate complexity, iterate toward better methods, and enable advancement in ways that matter both in the lab and beyond.